| Number of Patients, Male | 0 |
| Number of Patients, Female | 28 |
| Stage | II A — 5 |
| II B — 12 | |
| III A — 7 | |
| III B — 1 | |
| III C — 3 | |
| Age | Median: 48 years |
| Number of Prior Systemic Therapies | Median: 0 |
| Performance Status: ECOG |
0 — 27 1 — 1 2 — 3 — Unknown — |
| Other | |
| Receptor status | ER/PR‐postive — 15 |
| ER positive/PR negative — 4 | |
| ER neg/PR positive — 1 | |
| ER/PR negative — 8 | |
| Nuclear grade | Grade 1 — 3 |
| Grade 2 — 10 | |
| Grade 3 — 15 |